Voyager Therapeutics (VYGR) Preferred Stock Liabilities (2014 - 2016)
Voyager Therapeutics (VYGR) posted Preferred Stock Liabilities of $36.1 million for Q4 2016, little changed sequentially from $36.1 million in Q4 2015, and little changed YoY from $36.1 million in Q1 2016.
Voyager Therapeutics (VYGR) Preferred Stock Liabilities (2014 - 2016) Analysis & Trends
Voyager Therapeutics has reported Preferred Stock Liabilities for 3 years, with the latest figure at $36.1 million in Q4 2016.
- Quarterly Preferred Stock Liabilities changed 0.13% year-over-year to $36.1 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $36.1 million (changed 0.13% YoY) and the FY2016 annual result came in at $36.1 million, changed 0.13% from the prior year.
- Preferred Stock Liabilities was little changed at $36.1 million in Q4 2016 per VYGR's latest filing, from $36.1 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $89.0 million in Q3 2015 and troughed at $22.0 million in Q4 2014.
- A 3-year average of $45.8 million and a median of $36.1 million in 2015 frame the typical range for Preferred Stock Liabilities.
- The sharpest annual moves came in 2015 and 2016: Preferred Stock Liabilities jumped 64.04% in 2015, then rose 0.13% in 2016.
- Over 3 years, Preferred Stock Liabilities stood at $22.0 million in 2014, then jumped by 64.04% to $36.1 million in 2015, then increased by 0.13% to $36.1 million in 2016.
- According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $36.1 million, $36.1 million, and $89.0 million for Q4 2016, Q4 2015, and Q3 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 36.10 Mn |
| Dec 31, 2015 | 36.05 Mn |
| Sep 30, 2015 | 89.00 Mn |
| Dec 31, 2014 | 21.98 Mn |